Cargando…

A Family With a Complex Phenotype Caused by Two Different Rare Metabolic Disorders: GLUT1 and Very-Long-Chain Fatty Acid Dehydrogenase (VLCAD) Deficiencies

GLUT1 Deficiency Syndrome (GLUT1-DS) is a rare and potentially treatable neurometabolic condition, caused by a reduced glucose transport into the brain and clinically characterized by an epileptic encephalopathy with movement disorders. A wide inter-intrafamilial phenotypic variability has been repo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Musumeci, Olimpia, Ferlazzo, Edoardo, Rodolico, Carmelo, Gambardella, Antonio, Gagliardi, Monica, Aguglia, Umberto, Toscano, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7324651/ https://www.ncbi.nlm.nih.gov/pubmed/32655480 http://dx.doi.org/10.3389/fneur.2020.00514

Ejemplares similares

Diagnostic Challenges in Late Onset Multiple Acyl-CoA Dehydrogenase Deficiency: Clinical, Morphological, and Genetic Aspects
por: Lupica, Antonino, et al.
Publicado: (2022)

Case Report: Thymidine Kinase 2 (TK2) Deficiency: A Novel Mutation Associated With Childhood-Onset Mitochondrial Myopathy and Atypical Progression
por: Manini, Arianna, et al.
Publicado: (2022)

Cardiac Hypertrophy in Mice with Long-Chain Acyl-CoA Dehydrogenase (LCAD) or Very Long-Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency
por: Cox, Keith B., et al.
Publicado: (2009)

Renal response to short- and long-term exercise in very-long-chain acyl-CoA dehydrogenase-deficient (VLCAD(−/−)) mice
por: Tucci, Sara, et al.
Publicado: (2014)

Metabolic Outcomes of Anaplerotic Dodecanedioic Acid Supplementation in Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficient Fibroblasts
por: Radzikh, Igor, et al.
Publicado: (2021)

Postmortem diagnosis of very long chain acyl‐CoA dehydrogenase (VLCAD) deficiency in a neonate with sudden cardiac death
por: Singh, Prapti, et al.
Publicado: (2023)

Vacuolated PAS-Positive Lymphocytes on Blood Smear: An Easy Screening Tool and a Possible Biomarker for Monitoring Therapeutic Responses in Late Onset Pompe Disease (LOPD)
por: Parisi, Daniela, et al.
Publicado: (2018)

Tissue-Specific Strategies of the Very-Long Chain Acyl-CoA Dehydrogenase-Deficient (VLCAD(−/−)) Mouse to Compensate a Defective Fatty Acid β-Oxidation
por: Tucci, Sara, et al.
Publicado: (2012)

Two siblings with very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency suffered from rhabdomyolysis after l-carnitine supplementation
por: Watanabe, Kenji, et al.
Publicado: (2018)

MuSK-Associated Myasthenia Gravis: Clinical Features and Management
por: Rodolico, Carmelo, et al.
Publicado: (2020)

Psychiatric and Behavioural Side Effects Associated With Perampanel in Patients With Temporal Lobe Epilepsy. A Real-World Experience
por: Mammì, Anna, et al.
Publicado: (2022)

Late and Severe Myopathy in a Patient With Glycogenosis VII Worsened by Cyclosporine and Amiodarone
por: Filosto, Massimiliano, et al.
Publicado: (2019)

Positivity to p-ANCA in patients with status epilepticus
por: Ferlazzo, Edoardo, et al.
Publicado: (2014)

The Natural History of Epilepsy in 163 Untreated Patients: Looking for “Oligoepilepsy”
por: Gasparini, Sara, et al.
Publicado: (2016)

Clinical, Molecular, and Functional Characterization of CLCN1 Mutations in Three Families with Recessive Myotonia Congenita
por: Portaro, Simona, et al.
Publicado: (2015)

Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates
por: Knottnerus, Suzan J. G., et al.
Publicado: (2020)

Profile of brivaracetam and its potential in the treatment of epilepsy
por: Ferlazzo, Edoardo, et al.
Publicado: (2015)

S3.1 Are there ERT defined guidelines for Pompe disease?
por: Toscano, Antonio, et al.
Publicado: (2011)

S2.3 Therapeutic approaches in the late onset form of GSD II
por: Musumeci, Olimpia, et al.
Publicado: (2011)

Early is better? A new algorithm for early diagnosis in Late Onset Pompe Disease (LOPD)
por: TOSCANO, ANTONIO, et al.
Publicado: (2013)

Structural basis for defective membrane targeting of mutant enzyme in human VLCAD deficiency
por: Prew, Michelle S., et al.
Publicado: (2022)

Paraneoplastic neurological syndromes of the central nervous system: a single institution 7-year case series
por: Giammello, Fabrizio, et al.
Publicado: (2023)

Lipomatosis Incidence and Characteristics in an Italian Cohort of Mitochondrial Patients
por: Musumeci, Olimpia, et al.
Publicado: (2019)

Clinical course in a patient with myopathic VLCAD deficiency during pregnancy with an affected baby
por: Yamada, Kenji, et al.
Publicado: (2019)

Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Do not Improve with Carnitine Supplementation
por: Verkerk, Arie O., et al.
Publicado: (2021)

Statins Neuromuscular Adverse Effects
por: Attardo, Silvia, et al.
Publicado: (2022)

A Challenging Diagnosis of Atypical Glut1-DS: A Case Report and Literature Review
por: Yu, Miaomiao, et al.
Publicado: (2021)

Abnormal VLCADD newborn screening resembling MADD in four neonates with decreased riboflavin levels and VLCAD activity
por: Hagemeijer, Marne C., et al.
Publicado: (2021)

CACNA1A-Linked Hemiplegic Migraine in GLUT 1 Deficiency Syndrome: A Case Report
por: Scoppola, Chiara, et al.
Publicado: (2021)

Molecular Genetics Overview of Primary Mitochondrial Myopathies
por: Arena, Ignazio Giuseppe, et al.
Publicado: (2022)

Long-Term Effect of GPi-DBS in a Patient With Generalized Dystonia Due to GLUT1 Deficiency Syndrome
por: Hanci, Idil, et al.
Publicado: (2018)

Treatment of VLCAD-Deficient Patient Fibroblasts with Peroxisome Proliferator-Activated Receptor δ Agonist Improves Cellular Bioenergetics
por: D’Annibale, Olivia M., et al.
Publicado: (2022)

Late-onset fabry disease due to the p.Phe113Leu variant: the first italian cluster of five families
por: Cianci, Vittoria, et al.
Publicado: (2023)

Cerebrospinal Fluid Pressure-Related Features in Chronic Headache: A Prospective Study and Potential Diagnostic Implications
por: Bono, Francesco, et al.
Publicado: (2018)

Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study
por: Camerino, Giulia M., et al.
Publicado: (2017)

Endocrine myopathies: clinical and histopathological features of the major forms
por: Rodolico, Carmelo, et al.
Publicado: (2020)

Short Chain Fatty Acids Protect the Cognitive Function of Sepsis Associated Encephalopathy Mice via GPR43
por: Liao, Hongsen, et al.
Publicado: (2022)

Cardiovascular Risks of Ketogenic Diet for Glut-1 Deficiency
por: Spalice, Alberto, et al.
Publicado: (2018)

Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK/PPAR-α/VLCAD pathway
por: Bai, Fan, et al.
Publicado: (2019)

Late-Onset Ictal Asystole and Falls Related to Severe Coronary Artery Stenosis: A Case Report
por: Fortunato, Francesco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o79a11jpb9a3h5ncchuj8pjuk7